CCL5 and neuroblastoma: The intratumoural delivery of the oncolytic adenovirus, armed to express chemokine CCL5 and growth factor IL-15, enhanced tumour infiltration and the persistence of anti-GD2 CAR T cells in an immunodeficient mouse model of neuroblastoma–improving tumour control and survival as compared to monotherapies [74].